Aldosterone: a mediator of myocardial necrosis and renal arteriopathy
- PMID: 11014244
- DOI: 10.1210/endo.141.10.7711
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy
Abstract
To determine the role of aldosterone in mediating cardiovascular damage, we performed ablation/replacement experiments with aldosterone in a rat model of cardiac injury. Administration of angiotensin II and Nomega-nitro-L-arginine methyl ester (L-NAME; nitric oxide synthesis inhibitor) to male rats drinking 1% saline caused hypertension, severe biventricular myocardial necrosis, proteinuria, and fibrinoid necrosis of renal and cardiac vessels. Removal of aldosterone by adrenalectomy or through administration of the selective aldosterone antagonist eplerenone markedly reduced the cardiac and renal damage without significantly altering blood pressure. Aldosterone infusion in adrenalectomized, glucocorticoid-replaced L-NAME/angiotensin II-treated animals restored damage. Thus, we identified aldosterone as a critical mediator of L-NAME/angiotensin II induced vascular damage through mechanisms apparently independent of its effects on systolic blood pressure.
Similar articles
-
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.Circulation. 2003 Nov 18;108(20):2517-23. doi: 10.1161/01.CIR.0000097000.51723.6F. Epub 2003 Oct 27. Circulation. 2003. PMID: 14581407
-
Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.Endocrinology. 2002 Dec;143(12):4828-36. doi: 10.1210/en.2002-220120. Endocrinology. 2002. PMID: 12446610
-
Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.Endocrinology. 2015 Jul;156(7):2657-66. doi: 10.1210/en.2014-1369. Epub 2015 Apr 14. Endocrinology. 2015. PMID: 25872005
-
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.Hypertens Res. 2007 Jan;30(1):63-75. doi: 10.1291/hypres.30.63. Hypertens Res. 2007. PMID: 17460373
-
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.Hypertension. 2002 Feb;39(2 Pt 2):614-8. Hypertension. 2002. PMID: 11882618
Cited by
-
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.Kidney Int. 2012 Sep;82(6):643-51. doi: 10.1038/ki.2012.170. Epub 2012 May 23. Kidney Int. 2012. PMID: 22622494 Free PMC article.
-
The use of selective aldosterone antagonists.Curr Hypertens Rep. 2004 Oct;6(5):342-5. doi: 10.1007/s11906-004-0051-3. Curr Hypertens Rep. 2004. PMID: 15341684 Review.
-
Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1.Clin Exp Nephrol. 2012 Feb;16(1):81-8. doi: 10.1007/s10157-011-0498-x. Epub 2011 Nov 1. Clin Exp Nephrol. 2012. PMID: 22042038 Review.
-
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.J Pharmacol Exp Ther. 2015 Oct;355(1):32-47. doi: 10.1124/jpet.115.226043. Epub 2015 Jul 16. J Pharmacol Exp Ther. 2015. PMID: 26183312 Free PMC article.
-
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.Am J Nephrol. 2009;30(2):140-6. doi: 10.1159/000209744. Epub 2009 Mar 20. Am J Nephrol. 2009. PMID: 19299892 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical